Boston Business JournalFidelity gets in on $100M round for gene therapy startup Generation BioBoston Business Journal… 2016, supplying the entire $25 million that made up its Series A round, although the company did not announce its launch until Jan… Continue reading
Markets InsiderSenti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based TherapiesMarkets InsiderSOUTH SAN FRANCISCO, Calif., Feb. 27, 2018 /PRNewswire/ — Senti Biosciences, the synthetic biology company developing next… Continue reading
Senti launches to improve cell therapies with synthetic gene circuitsChemical & Engineering NewsAfter spending more than a decade developing these genetic circuits in the lab, synthetic biologists Lu, Jim Collins, and Phillip Lee from MIT, along with … Continue reading
FierceBiotechNEA powers next-generation cell and gene therapy startup Senti to $53MA roundFierceBiotechNew Enterprise Associates (NEA) has led a $53 million bet on the future of cell and gene therapies. The series A round sets JLABS resident Senti Bios… Continue reading
Endpoints News |
Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectors
Endpoints News A gene therapy company headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The 2-year-old startup captured investors’ attention by suggesting it knows a better way to do gene transfer than the potentially toxic … Fidelity gets in on $100M round for gene therapy startup Generation BioBoston Business Journal Generation Bio Announces $100 Million Series B Financing to Advance GeneWave™ Platform for Re-Dosable Gene …Business Wire (press release) |
Business Insider |
We’re at the beginning of ‘a big new field of medicine’ — and one startup just got $53 million to supercharge it
Business Insider Biotech startup Senti Biosciences just raised $53 million from investors including New Enterprise Associates, 8VC, and Menlo Ventures. The startup’s aim is to create “circuits” using synthetic biology that could better program cell therapies to be … Synthetic Bio Startup Senti Raises $53M to Program Cells to Treat DiseaseXconomy NEA powers next-generation cell and gene therapy startup Senti to $53MA roundFierceBiotech |
The Hindu |
NCCS finds dual mechanism to help embryonic stem cells maintain pluripotency
The Hindu Embryonic stem cells are capable of generating all the cell types that compose the organs and systems of the human body. Now, researchers at Pune’s National Centre for Cell Science (NCCS) have found a dual mechanism that keeps specific genes off, which … |
The Hindu |
NCCS finds dual mechanism to help embryonic stem cells maintain pluripotency
The Hindu Embryonic stem cells are capable of generating all the cell types that compose the organs and systems of the human body. Now, researchers at Pune’s National Centre for Cell Science (NCCS) have found a dual mechanism that keeps specific genes off, which … |